Reply: Immunosuppressive cell death in cancer

Nature Reviews Immunology

Volumn 17, Issue 6, 2017, Pages 402-

  Galluzzi, Lorenzo ^a,b   Buqué, Aitziber ^b,c,d,e,f   Kepp, Oliver ^b,c,d,e,f   Zitvogel, Laurence ^e,f,g,h   Kroemer, Guido ^{b,c,d,e,f,i,j}  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c SORBONNE UNIVERSITÉ   (France)

^d CENTRE DE RECHERCHE DES CORDELIERS   (France)

^e INSERM   (France)

^f INSTITUT GUSTAVE ROUSSY   (France)

^g Center of Clinical Investigations in Biotherapies of Cancer   (France)

^h UNIVERSITÉ PARIS SACLAY   (France)

ⁱ KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^j HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CANCER CELL; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CELL DEATH; HUMAN; IMMUNOGENIC CELL DEATH; IMMUNOLOGICAL TOLERANCE; IMMUNOSURVEILLANCE; LETTER; MALIGNANT NEOPLASM; PRIORITY JOURNAL; TUMOR IMMUNITY; COMMUNICABLE DISEASE; NEOPLASM;

IMMUNOSUPPRESSIVE AGENT;

CELL DEATH; COMMUNICABLE DISEASES; HUMANS; IMMUNOSUPPRESSIVE AGENTS; NEOPLASMS;

EID: 85019733810     PISSN: 14741733     EISSN: 14741741     Source Type: Journal    
DOI: 10.1038/nri.2017.48     Document Type: Letter

References (14)

1. Galluzzi, L., Buque, A., Kepp, O., Zitvogel, L. & Kroemer, G. Immunogenic cell death in cancer and infectious disease. Nat. Rev. Immunol. 17, 97-111 (2017).
2. Bettigole, S. E. & Glimcher, L. H. Endoplasmic reticulum stress in immunity. Annu. Rev. Immunol. 33, 107-138 (2015).
3. Galluzzi, L., Bravo-San Pedro, J. M., Levine, B., Green, D. R. & Kroemer, G. Pharmacological modulation of autophagy: therapeutic potential and persisting obstacles. Nat. Rev. Drug Discov. http:// dx.doi.org/10.1038/nrd.2017.22 (2017).
4. Krysko, D. V. et al. Immunogenic cell death and DAMPs in cancer therapy. Nat. Rev. Cancer 12, 860-875 (2012).
5. Kroemer, G., Galluzzi, L., Kepp, O. & Zitvogel, L. Immunogenic cell death in cancer therapy. Annu. Rev. Immunol. 31, 51-72 (2013).
6. Fucikova, J. et al. Prognostic and predictive value of DAMPs and DAMP-associated processes in cancer. Front. Immunol. 6, 402 (2015).
7. Fucikova, J. et al. Calreticulin exposure by malignant blasts correlates with robust anticancer immunity and improved clinical outcome in AML patients. Blood 128, 3113-3124 (2016).
8. Bidwell, B. N. et al. Silencing of Irf7 pathways in breast cancer cells promotes bone metastasis through immune escape. Nat. Med. 18, 1224-1231 (2012).
9. Katlinski, K. V. et al. Inactivation of interferon receptor promotes the establishment of immune privileged tumor microenvironment. Cancer Cell 31, 194-207 (2017).
10. Mohme, M., Riethdorf, S. & Pantel, K. Circulating and disseminated tumour cells - mechanisms of immune surveillance and escape. Nat. Rev. Clin. Oncol. 14, 155-167 (2017).
11. Dewan, M. Z. et al. Fractionated but not single-dose radiotherapy induces an immune-mediated abscopal effect when combined with anti-CTLA 4 antibody. Clin. Cancer Res. 15, 5379-5388 (2009).
12. Pasquier, E., Kavallaris, M. & Andre, N. Metronomic chemotherapy: new rationale for new directions. Nat. Rev. Clin. Oncol. 7, 455-465 (2010).
13. Vanpouille-Box, C. et al. DNA exonuclease Trex1 regulates radiotherapy-induced tumor immunogenicity. Nat. Commun. (in the press) (2017).
14. Galluzzi, L., Bravo-San Pedro, J. M., Demaria, S., Formenti, S. C. & Kroemer, G. Activating autophagy to potentiate immunogenic chemotherapy and radiation therapy. Nat. Rev. Clin. Oncol. 14, 247-258 (2017).